Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label multicentre quetiapine biomarker and PET study in schizophrenia
ISRCTN93019988Phase 4Completed
- Sponsor
- Klinikum Fulda
- Start
- Dec 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of quetiapine in schizophrenia, sponsored by Klinikum Fulda. Started Dec 2006; status: completed.
02
Drugs
quetiapine
03
Conditions
schizophrenia
Beyond the preview
Go deeper on ISRCTN93019988.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN93019988.